BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MLF1, P58340, 4291, ENSG00000178053 AND Treatment
5 results:

  • 1. Long-term outcomes and early recurrence after resection for metachronous pulmonary metastases from colorectal cancer.
    Hashimoto S; Tominaga T; Nonaka T; Noda K; Kiya S; Shiraishi T; Oishi K; Takamura Y; Yamazaki S; Araki M; Sumida Y; Miyazaki T; Kamohara R; Morino S; Matsumoto K; Nakamura A; Nagayasu T
    Langenbecks Arch Surg; 2023 Dec; 409(1):24. PubMed ID: 38158429
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exercise and colorectal cancer: a systematic review and meta-analysis of exercise safety, feasibility and effectiveness.
    Singh B; Hayes SC; Spence RR; Steele ML; Millet GY; Gergele L
    Int J Behav Nutr Phys Act; 2020 Sep; 17(1):122. PubMed ID: 32972439
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive Potential of PD-L1, TYMS, and DCC Expressions in treatment Outcome of colorectal Carcinoma.
    Onwe EE; Ghani FA; Abdullah M; Osman M; Zin RRM; Vivian AN; Mohtarrudin N
    Adv Exp Med Biol; 2020; 1292():97-112. PubMed ID: 32542457
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A systematic review of repeat hepatectomy for recurrent colorectal liver metastases.
    Lam VW; Pang T; Laurence JM; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
    J Gastrointest Surg; 2013 Jul; 17(7):1312-21. PubMed ID: 23525970
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis.
    Chen J; Ye Y; Sun H; Shi G
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):265-72. PubMed ID: 23090619
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.